NantHealth, Inc. (NHIQ)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NantHealth, Inc. (NHIQ) trades at $0.01 with AI Score 52/100 (Grade B). NantHealth, Inc. Market cap: $329,656, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for NHIQ: NHIQ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NHIQ against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
NHIQ: the 1 perspectives are evenly split.
How is this calculated? →NantHealth, Inc. (NHIQ) Healthcare & Pipeline Overview
NantHealth, Inc. delivers healthcare IT solutions, specializing in SaaS-based clinical decision support for oncology, payer-provider communication platforms, and enterprise network monitoring. Operating across the US, Canada, and UK, the company addresses complexities in cancer care pre-authorization and streamlines information exchange within the healthcare ecosystem.
What Is the Investment Thesis for NHIQ?
NantHealth, Inc. operates within the critical and evolving healthcare IT sector, providing specialized SaaS solutions that address key industry challenges. The company's Eviti platform, focused on clinical decision support and pre-authorization automation for cancer care, represents a significant value driver by aiming to improve treatment efficacy and reduce administrative burdens. The NaviNet suite further enhances this by streamlining payer-provider communication, a persistent bottleneck in healthcare. With a gross margin of 57.0%, the company demonstrates efficiency in its service delivery. However, the reported profit margin of -101.2% indicates substantial operational losses, which is a primary risk factor. The company's market capitalization of 330K and its trading on the OTC market also present liquidity and transparency challenges. Future growth could be catalyzed by increased adoption of its specialized oncology solutions, broader integration of its payer-provider platforms, and potential expansion of its data analytics services, provided it can achieve profitability and scale its operations effectively.
Based on FMP financials and quantitative analysis
NHIQ Key Highlights
- Gross Margin: 57.0%, indicating strong profitability on services rendered before accounting for operating expenses.
- Profit Margin: -101.2%, highlighting significant net losses relative to revenue, underscoring operational challenges.
- Market Capitalization: $0.00B, suggesting a very small market valuation and potentially limited trading liquidity.
- Employee Base: 365 employees, supporting its healthcare IT operations across the United States, Canada, and the United Kingdom.
- Beta: -5.74, indicating a high degree of inverse volatility relative to the broader market, suggesting significant price fluctuations.
Who Are NHIQ's Competitors?
NHIQ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| RCM R1 RCM Inc. | $14.31 | +0.00% | $6.04B | 54 |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.72 | +3.54% | $8.46M | 54 |
| CERN Cerner Corporation | $94.92 | +0.00% | 54 | |
| CRVW CareView Communications, Inc. | $0.05 | -8.31% | $30.65M | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NHIQ's Key Strengths?
- Specialized SaaS solutions for oncology clinical decision support and pre-authorization automation (Eviti).
- Comprehensive payer-provider communication and information exchange platforms (NaviNet).
- Established geographic presence in the United States, Canada, and the United Kingdom.
- Diverse product portfolio including network monitoring (OpenNMS) and data solutions (Quadris).
What Are NHIQ's Weaknesses?
- Significant negative profit margin (-101.2%), indicating ongoing operational losses.
- Very low market capitalization ($0.00B), suggesting limited financial scale and market presence.
- Trading on the OTC market, which typically entails lower liquidity and transparency compared to major exchanges.
- Status as a subsidiary of NantWorks, LLC, which may influence strategic autonomy and public disclosures.
What Could Drive NHIQ Stock Higher?
- Increasing adoption of NantHealth's Eviti solutions for oncology pre-authorization and clinical decision support, driven by the healthcare industry's push for efficiency and evidence-based care.
- Expansion of the NaviNet platform's network, leading to broader integration for payer-provider communication and streamlined administrative processes across more health systems.
- Sustained demand for healthcare IT solutions that improve operational efficiency, reduce costs, and enhance data management within the complex healthcare ecosystem.
- Potential for new partnerships or client acquisitions that expand the reach and utilization of NantHealth's specialized software offerings in existing markets.
What Are the Key Risks for NHIQ?
- Financial-distress signal — its Altman Z-Score of -13.34 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Sustained negative profit margin of -101.2%, indicating significant operational losses that could impact long-term financial viability.
- Extremely low market capitalization ($0.00B) and trading on the OTC market, which inherently carries risks of limited liquidity, price volatility, and reduced transparency.
- Intense competition within the highly dynamic healthcare IT sector, potentially impacting market share and pricing power for NantHealth's solutions.
- Adverse regulatory changes or shifts in healthcare policy that could impact the demand for or reimbursement of NantHealth's products and services.
- Risks associated with data security breaches or privacy concerns, given the company's role in handling sensitive patient and healthcare information.
What Are the Growth Opportunities for NHIQ?
- Growth opportunity 1: Expansion of Eviti's Oncology Decision Support. The global oncology market continues to grow, driving demand for precise and efficient treatment planning. Eviti's ability to centralize clinical content, cost data, and toxicity data for pre-authorization automation positions NantHealth to capture a larger share of this market. As healthcare systems increasingly prioritize evidence-based medicine and cost containment, solutions that streamline complex cancer care decisions and approvals are becoming indispensable. This represents an ongoing opportunity for deeper penetration within existing markets and potential expansion to new healthcare systems seeking to optimize their oncology pathways.
- Growth opportunity 2: Broadening NaviNet's Payer-Provider Network. The healthcare industry consistently seeks to improve communication and data exchange between health plans and providers to reduce administrative overhead and enhance patient care coordination. NaviNet's suite of SaaS-based solutions, including NaviNet Open and NaviNet AllPayer, directly addresses this need. By expanding its network of participating payers and providers, NantHealth can increase the utility and value proposition of its platform, fostering greater adoption and recurring revenue streams. The ongoing push for interoperability and seamless information flow within healthcare systems provides a fertile ground for NaviNet's continued growth.
- Growth opportunity 3: Leveraging OpenNMS in Enterprise Markets. While primarily a healthcare IT company, NantHealth also offers OpenNMS, an open-source network monitoring solution for enterprise-grade networks. This product presents an opportunity to diversify revenue streams beyond the core healthcare sector by targeting general enterprise clients that require robust and scalable network management tools. The increasing complexity of IT infrastructures across all industries necessitates advanced monitoring capabilities, and OpenNMS could be positioned to serve this broader market. This diversification could mitigate some of the risks associated with a sole focus on healthcare-specific solutions.
- Growth opportunity 4: Data Analytics and Professional Services with Quadris. The proliferation of healthcare data creates a significant demand for sophisticated analysis, reporting, and professional services to extract actionable insights. NantHealth's Quadris solution, which includes multi-data analysis and reporting, is well-positioned to capitalize on this trend. As healthcare organizations strive to optimize operations, improve patient outcomes, and comply with regulatory requirements, the need for expert data interpretation and customized reporting will only intensify. Expanding the scope and client base for Quadris could unlock new revenue opportunities and strengthen client relationships by providing comprehensive data intelligence.
- Growth opportunity 5: Geographic Penetration within Existing Markets. NantHealth currently operates in the United States, Canada, and the United Kingdom. Rather than immediate expansion into entirely new countries, there is a significant opportunity for deeper market penetration within these established geographies. This involves expanding the client base for Eviti and NaviNet within existing regions, securing more contracts with health systems and payers, and increasing the utilization of its various platforms. Leveraging existing operational infrastructure and market knowledge can lead to more efficient growth and stronger market share in these key territories.
What Opportunities Does NHIQ Have?
- Growing demand for healthcare IT solutions that enhance efficiency, reduce costs, and support evidence-based medicine.
- Potential for deeper market penetration and increased adoption of its specialized oncology solutions (Eviti).
- Expansion of its payer-provider collaboration platforms (NaviNet) to new health systems and plans.
- Leveraging its data analytics and professional services (Quadris) to meet the increasing need for healthcare data insights.
What Threats Does NHIQ Face?
- Intense and evolving competition within the broader healthcare IT sector from both established players and new entrants.
- Potential for adverse regulatory changes in healthcare that could impact product adoption, reimbursement, or compliance requirements.
- Risks associated with data security breaches and privacy concerns, given its handling of sensitive healthcare information.
- Economic downturns or shifts in healthcare spending priorities that could reduce demand for IT solutions.
What Are NHIQ's Competitive Advantages?
- Specialized clinical content and treatment cost data for oncology, integrated into its Eviti platform, creating a high barrier to entry for competitors.
- Comprehensive, integrated SaaS platform for payer-provider collaboration (NaviNet), streamlining complex administrative workflows.
- Proprietary pre-authorization automation technology specifically designed for the intricacies of cancer care, offering efficiency gains.
- Established operational presence and client base within the healthcare IT sectors of the United States, Canada, and the United Kingdom.
What Does NHIQ Do?
NantHealth, Inc., incorporated in 2010 as Nant Health, LLC, evolved into its current form in June 2016 and operates as a subsidiary of NantWorks, LLC. Headquartered in Morrisville, North Carolina, the company functions as a healthcare IT provider across the United States, Canada, and the United Kingdom, employing 365 individuals. Its core offerings are centered around enhancing clinical decision-making and streamlining administrative processes within the healthcare sector. A flagship product is Eviti, a sophisticated software-as-a-service (SaaS) based clinical decision support solution. Eviti centralizes critical clinical content, treatment cost data derived from Medicare reimbursements, and comprehensive treatment toxicity data, primarily for oncology. This platform is further leveraged through Eviti Connect, which provides pre-authorization automation to assist both payers and providers in navigating the intricate landscape of cancer care, and Eviti Advisor, enabling physicians to access Eviti's extensive library of evidence-based treatment standards and protocols to inform patient care decisions. Beyond oncology, NantHealth offers NaviNet, a suite of SaaS-based solutions designed to facilitate communication and information consolidation between payers and providers. This includes NaviNet Open, a dedicated payer-provider collaboration platform, and NaviNet AllPayer, which delivers essential eligibility, benefit, and claim status information to provider offices for commercial, government, and Medicare plans via the NaviNet portal. Additionally, the company extends its technological reach with OpenNMS, an open-source network monitoring solution tailored for enterprise-grade networks, and Quadris, a data solution encompassing multi-data analysis, reporting, and professional services.
What Products and Services Does NHIQ Offer?
- Provide SaaS clinical decision support for cancer treatment, centralizing clinical content and cost data (Eviti).
- Automate pre-authorization processes for complex cancer care for payers and providers (Eviti Connect).
- Offer physicians access to evidence-based treatment standards and protocols to inform decisions (Eviti Advisor).
- Deliver a suite of SaaS solutions to streamline communication and consolidate information between healthcare payers and providers (NaviNet).
- Facilitate real-time collaboration between health plans and providers through a dedicated platform (NaviNet Open).
- Provide eligibility, benefit, and claim status information to provider offices for various health plans, including Medicare (NaviNet AllPayer).
- Offer an open-source network monitoring solution designed for enterprise-grade networks (OpenNMS).
- Supply data analysis, reporting, and professional services to help clients manage and interpret multi-source data (Quadris).
How Does NHIQ Make Money?
- Generates revenue through subscription-based fees for its software-as-a-service (SaaS) platforms, such as Eviti and NaviNet.
- Earns income from pre-authorization automation services, particularly through its Eviti Connect solution for cancer care.
- Derives revenue from the provision of data analysis, reporting, and professional services under its Quadris offering.
- Monetizes its OpenNMS network monitoring solution through licensing, support, or related service agreements for enterprise clients.
What Industry Does NHIQ Operate In?
NantHealth, Inc. operates within the dynamic and rapidly expanding Medical - Healthcare Information Services industry, a sector driven by the increasing demand for digital transformation, efficiency, and evidence-based care. The company's focus on SaaS-based solutions for clinical decision support in oncology and payer-provider communication positions it within a market seeking to reduce costs, improve patient outcomes, and streamline complex administrative processes. Key market trends include the push for interoperability, the adoption of AI and data analytics in healthcare, and the growing need for robust cybersecurity. NantHealth competes by offering specialized platforms like Eviti for cancer care pre-authorization and NaviNet for network communication, addressing specific pain points in the healthcare ecosystem. Its presence in the US, Canada, and UK allows it to tap into diverse healthcare systems, each with unique regulatory and operational demands.
Who Are NHIQ's Key Customers?
- Healthcare payers, including insurance companies and various health plans in the US, Canada, and UK.
- Healthcare providers, such as hospitals, clinics, physician offices, and specialized oncology practices.
- Enterprise-grade organizations across various industries requiring robust network monitoring solutions for their IT infrastructure (for OpenNMS).
- Government health programs and centers for Medicare and Medicaid services beneficiaries through its NaviNet AllPayer product.
FY2026 estForward Outlook
Wall Street analysts project NantHealth, Inc. revenue of about $170.4M for fiscal 2026, with EPS near $1.35.
F-Score 3/9Financial Health
NantHealth, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -13.34 places it in the distress zone, a signal of elevated financial risk.
ROE 35%Key Financial Metrics
Return on equity for NantHealth, Inc. stands at 35.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -42.5%, showing how much profit it generates from its asset base. A current ratio of 0.35 means current liabilities exceed short-term assets, a liquidity point worth watching.
NantHealth, Inc. (NHIQ) Valuation Context
Valued at 330K, NHIQ is classified as a micro-cap stock. Relative to its peer group, NHIQ's quantitative score of 52/100 is below the peer average of 65/100.
Company Profile
NantHealth, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Morrisville, US. The company is led by CEO Rao Haris Naseem FACC,. NHIQ has traded publicly since 2016.
NHIQ Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that key stakeholders believe in its potential.
- Community sentiment has shifted positively, with discussions highlighting the innovative healthcare solutions NantHealth is providing.
- Analysts have pointed out that strategic partnerships could enhance NantHealth's market position, boosting investor interest.
- The growing focus on digital health solutions aligns well with NantHealth's offerings, attracting attention from both consumers and investors.
Bear Case
- Concerns over the company's profitability persist, with many investors questioning its ability to generate sustainable revenue in the long term.
- Negative community sentiment has emerged due to recent operational challenges, leading to skepticism about management's effectiveness.
- Market perception is clouded by broader economic uncertainties, which could impact investment in healthcare technologies.
- Some analysts believe that competition in the digital health space is intensifying, potentially limiting NantHealth's growth prospects.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
NHIQ Latest News
No recent news available for NHIQ.
NHIQ Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NHIQ.
Price Targets
Wall Street price target analysis for NHIQ.
NHIQ MoonshotScore
What does this score mean?
The MoonshotScore rates NHIQ's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Rao Haris Naseem FACC,
CEO
Rao Haris Naseem FACC, serves as the CEO of NantHealth, Inc., overseeing the company's strategic direction and operations. While specific details regarding his prior career history, educational background, or previous roles are not provided in the available information, his FACC credential typically signifies a Fellow of the American College of Cardiology, indicating a strong background in cardiology and potentially broader healthcare. In his current capacity, he is responsible for managing the company's 365 employees and guiding its efforts in delivering healthcare IT solutions across its operational geographies.
Track Record: Specific key achievements, strategic decisions, or company milestones directly attributable to Rao Haris Naseem FACC's leadership tenure at NantHealth are not detailed in the provided source data. His role involves managing the company's operations and strategic initiatives within the healthcare IT sector.
NHIQ OTC Market Information
NantHealth, Inc. trades on the 'OTC Other' tier of the OTC market. This tier typically includes companies that do not meet the financial or disclosure requirements for higher tiers like OTCQX or OTCQB, or those that choose not to provide comprehensive disclosures. Unlike companies listed on major exchanges such as NYSE or NASDAQ, which adhere to stringent reporting and governance standards, companies on the 'OTC Other' tier often have less public financial information and fewer regulatory oversight requirements, which can impact investor access to critical data and overall market transparency.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public information and transparency due to less stringent reporting requirements on the OTC Other tier.
- Potentially low trading volume and wide bid-ask spreads, leading to poor liquidity and difficulty in executing trades.
- Increased susceptibility to price manipulation and speculative trading due to less regulatory oversight.
- Lack of analyst coverage and institutional interest, which can hinder accurate valuation and market awareness.
- Higher volatility and unpredictable price movements, as indicated by its Beta of -5.74.
- Verify any available financial statements and reports, even if less frequent or comprehensive than those for exchange-listed companies.
- Thoroughly research the management team, including their professional backgrounds and any public records.
- Understand the company's full ownership structure, particularly its relationship as a subsidiary of NantWorks, LLC.
- Assess the fundamental business operations, product market fit, and competitive landscape independently.
- Check for any regulatory filings or news releases that might provide additional insight into the company's status.
- Evaluate the market demand for NantHealth's specific healthcare IT products and services.
- Consider the potential for delisting or further restrictions if disclosure requirements are not met.
- Operates in multiple geographies including the United States, Canada, and the United Kingdom.
- Offers specific, defined healthcare IT products and services such as Eviti, NaviNet, OpenNMS, and Quadris.
- Incorporated in 2010, indicating a decade-plus operational history.
- Employs 365 individuals, suggesting a tangible operational footprint.
- Is a subsidiary of NantWorks, LLC, an established entity, providing a degree of corporate backing.
Common Questions About NHIQ (Healthcare)
What are NantHealth, Inc.'s primary healthcare IT solutions and their target markets?
NantHealth, Inc. offers a diverse portfolio of healthcare IT solutions. Its flagship Eviti platform provides SaaS-based clinical decision support for oncology, centralizing clinical content, treatment cost data, and toxicity information to assist payers and providers in cancer care pre-authorization and treatment decisions. The NaviNet suite focuses on streamlining communication and information exchange between healthcare payers and providers, offering solutions like NaviNet Open for collaboration and NaviNet AllPayer for eligibility and claim status. Additionally, NantHealth provides OpenNMS, an open-source network monitoring solution for enterprise-grade networks, and Quadris, a data solution for multi-data analysis and professional services. These solutions primarily target healthcare payers, providers (hospitals, clinics, physician offices), and enterprises requiring robust network management.
How does NantHealth, Inc. position itself within the evolving healthcare IT landscape?
NantHealth, Inc. positions itself as a provider of specialized, SaaS-based healthcare IT solutions designed to address critical inefficiencies and complexities within the healthcare ecosystem. Its focus on oncology through the Eviti platform aligns with the growing demand for precision medicine and evidence-based cancer care, aiming to optimize treatment pathways and reduce costs associated with pre-authorization. Concurrently, the NaviNet suite tackles the persistent challenge of fragmented communication between payers and providers, a key area for operational improvement and cost reduction in healthcare administration. By offering these targeted solutions, NantHealth aims to enhance clinical decision-making, improve administrative efficiency, and facilitate better information flow, thereby contributing to the broader digital transformation trends within the healthcare industry across the US, Canada, and the UK.
What are the financial characteristics and risks associated with NantHealth, Inc. as an OTC-traded company?
NantHealth, Inc. exhibits several notable financial characteristics and risks, particularly given its status as an OTC-traded company. Financially, it reports a gross margin of 57.0%, indicating a solid margin on its services. However, this is significantly offset by a negative profit margin of -101.2%, suggesting substantial operational losses. The company's market capitalization is listed as $0.00B, which points to a very small valuation and potentially extremely low liquidity. Trading on the 'OTC Other' tier means less stringent disclosure requirements compared to major exchanges, leading to reduced transparency and potentially limited access to comprehensive financial information. This, combined with a Beta of -5.74, suggests high volatility and unpredictable price movements, making it a high-risk investment with potential challenges in trading execution and price discovery.
What are the key factors to evaluate for NHIQ?
NantHealth, Inc. (NHIQ) holds an AI score of 52/100 (moderate). Not financial advice.
How frequently does NHIQ data refresh on this page?
NHIQ prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NHIQ's recent stock price performance?
NantHealth, Inc. (NHIQ) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized SaaS solutions for oncology clinical decision support and pre-authorization automation (Eviti). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NHIQ overvalued or undervalued right now?
Valuing NantHealth, Inc. (NHIQ) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NHIQ?
Before investing in NantHealth, Inc. (NHIQ), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based solely on the provided source data. Specific details regarding CEO background, track record, and analyst consensus were not available in the provided text. Competitor information was also not provided.